0001567619-22-009719.txt : 20220506 0001567619-22-009719.hdr.sgml : 20220506 20220506201902 ACCESSION NUMBER: 0001567619-22-009719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220429 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guyer Charles Greg CENTRAL INDEX KEY: 0001811096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 22902991 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 770 LINDARO ST. CITY: SAN RAFAEL STATE: CA ZIP: 94901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2022-04-29 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001811096 Guyer Charles Greg C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, Chief Technical Officer Common Stock 2022-04-29 5 A 0 243 62.407 A 52299 D Common Stock 2022-05-04 4 F 0 3926 84.65 D 48373 D Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan. /s/ Eric Fleekop, Attorney-in-Fact 2022-05-06